JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2024  1,200
2023  1,500
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 60(2026) N 1 p. 21-35; DOI 10.1134/S0026893325700542 Full Text

R.N. Mustafin1*

Mechanisms of Interactions of Circular RNAs with Mobile Elements and MicroRNAs in the Development of Breast Cancer

1Bashkir State Medical University, Ministry of Health of the Russian Federation, Ufa, 450008 Russia

*ruji79@mail.ru
Received - 2025-06-07; Revised - 2025-09-05; Accepted - 2025-09-09

Transposable elements (TEs) make up 46.7% of all nucleotide sequences in the human genome and include retroelements and DNA transposons. They are the evolutionary sources of many protein-coding genes; regulatory sequences; and noncoding RNAs (ncRNAs), including circular RNAs and microRNAs.

TEs induce genomic instability, promote recombination events, inactivate tumor suppressor genes, and activate oncogenes, thus facilitating carcinogenesis. In addition, TE transcripts can competitively interact with specific microRNAs that serve as targets for circular RNAs. The common origin of microRNAs and circular RNAs originating from TEs suggests the presence of complementary sequences. TE transcripts therefore act as competing endogenous RNAs (ceRNAs) for microRNAs to level their inhibitory effect on target mRNAs.

An analysis of the literature revealed 12 transposon-derived microRNAs that interact with circular RNAs during breast carcinogenesis. The review is the first to consider the interactions between several RNA classes (TEs, circular RNAs, and microRNAs with their target mRNAs) in the pathogenesis of breast cancer (BC).

This allows a new insight into the mechanisms of carcinogenesis in BC for the development of highly specific targeted drugs.

breast cancer, carcinogenesis, circular RNAs, microRNAs, transposons



JMB-FOOTER RAS-JOURNALS